Baylor College of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Texas Heart Institute at St. Luke’s Episcopal Hospital, Houston, Texas 77030, USA.
Ann Thorac Surg. 2011 Mar;91(3):671-5. doi: 10.1016/j.athoracsur.2010.09.004.
Hypoalbuminemia is associated with increased morbidity in surgical patients. The impact of low albumin level on survival in cardiac surgical patients is unknown. We hypothesized that a low preoperative albumin level negatively affects long-term survival after coronary artery bypass graft (CABG) surgery.
We reviewed prospectively gathered data from the records of 1,164 consecutive patients who underwent primary isolated CABG at our institution between 1997 and 2007. Propensity score analysis of 18 preoperative and intraoperative variables balanced potential confounding factors between the two groups of patients, so that the final study cohort consisted of 588 patients: 294 with a preoperative albumin level less than 3.5 g/dL (ie, hypoalbuminemia) and 294 patients with a preoperative albumin level of 3.5 g/dL or greater. We assessed long-term survival by using Kaplan-Meier curves generated by log rank tests.
The two groups of patients were well matched in terms of preoperative and intraoperative covariates. Both groups had similar early outcomes, including 30-day mortality rates (2.0% versus 1.7%; p = 0. 76) and the incidence of major adverse cardiac events (2.7% versus 2.7%; p = 1.0). However, patients with hypoalbuminemia had a significantly worse 8-year survival rate (65% ± 7% versus 86% ± 3%; hazard ratio 2.2; 95% confidence interval: 1.4 to 3.6; p = 0.001) than patients without hypoalbuminemia.
Although preoperative hypoalbuminemia did not predict increased early postoperative mortality or morbidity in CABG patients, it did independently predict poor long-term survival after CABG. Identifying the mechanism that underlies this relationship is essential in improving overall survival among patients with low serum albumin levels who are undergoing surgical myocardial revascularization.
低白蛋白血症与外科患者的发病率增加有关。低白蛋白水平对心脏外科患者的生存影响尚不清楚。我们假设术前低白蛋白水平会对冠状动脉旁路移植术(CABG)后的长期生存产生负面影响。
我们回顾了 1997 年至 2007 年期间在我院接受单纯 CABG 的 1164 例连续患者的前瞻性收集数据。18 项术前和术中变量的倾向评分分析平衡了两组患者的潜在混杂因素,因此最终研究队列包括 588 例患者:294 例术前白蛋白水平<3.5 g/dL(即低白蛋白血症),294 例术前白蛋白水平为 3.5 g/dL 或更高。我们通过对数秩检验生成的 Kaplan-Meier 曲线评估长期生存情况。
两组患者在术前和术中协变量方面匹配良好。两组患者的早期结果相似,包括 30 天死亡率(2.0%对 1.7%;p = 0.76)和主要不良心脏事件发生率(2.7%对 2.7%;p = 1.0)。然而,低白蛋白血症患者的 8 年生存率明显较差(65%±7%对 86%±3%;风险比 2.2;95%置信区间:1.4 至 3.6;p = 0.001)低于无低白蛋白血症患者。
尽管术前低白蛋白血症并未预测 CABG 患者术后早期死亡率或发病率增加,但它确实独立预测了 CABG 后长期生存不良。确定这种关系背后的机制对于改善接受手术心肌血运重建的低血清白蛋白水平患者的总体生存率至关重要。